Roychowdhury Sameek, Blaser Bradley W, Freud Aharon G, Katz Kerry, Bhatt Darshna, Ferketich Amy K, Bergdall Valerie, Kusewitt Donna, Baiocchi Robert A, Caligiuri Michael A
Department of Molecular Virology, Immunology, and Medical Genetics, the Medical Scientist Program, the Integrated Biomedical Science Graduate Program, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Blood. 2005 Oct 1;106(7):2433-5. doi: 10.1182/blood-2005-04-1597. Epub 2005 Jun 23.
Interleukin-2 (IL-2) and IL-15 are structurally related cytokines that share receptor components but display markedly different effects in multiple in vivo model systems. Here we demonstrate that IL-15 but not IL-2 exacerbates xenogeneic graft-versus-host disease (X-GVHD) in severe combined immunodeficient murine recipients of human peripheral-blood lymphocytes (hu-PBL-SCID). Treatment of hu-PBL-SCID mice with IL-15 resulted in rapid fatality, lymphocytic infiltrations in the liver, lung, and spleen consistent with X-GVHD, and a marked expansion of human CD4+ and CD8+ T cells compared with controls. Depletion of human T cells in vivo abrogated the lethality of IL-15 treatment. To our knowledge, these data are the first to demonstrate in vivo activation and expansion of human T lymphocytes in response to IL-15 with concomitant exacerbation of human T-cell-mediated X-GVHD.
白细胞介素-2(IL-2)和IL-15是结构相关的细胞因子,它们共享受体成分,但在多个体内模型系统中表现出明显不同的效应。在此,我们证明,在接受人类外周血淋巴细胞(hu-PBL-SCID)的严重联合免疫缺陷小鼠受体中,IL-15而非IL-2会加剧异种移植物抗宿主病(X-GVHD)。用IL-15处理hu-PBL-SCID小鼠会导致快速死亡、肝脏、肺和脾脏中出现与X-GVHD一致的淋巴细胞浸润,并且与对照组相比,人类CD4+和CD8+T细胞显著扩增。体内人类T细胞的耗竭消除了IL-15治疗的致死性。据我们所知,这些数据首次证明了人类T淋巴细胞在体内因IL-15而激活和扩增,并伴随人类T细胞介导的X-GVHD加剧。